Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value.
Piers GillettRobert K MaharNancy R TranMark RosenthalMaarten J IJzermanPublished in: Cost effectiveness and resource allocation : C/E (2023)
We confirmed that the use of the decision tool for valuing clinical trials is feasible and that the results are face valid based on the evaluation of six trials. A proof-of-concept applying this tool to a larger set of trials with an external validation is currently underway.